1. Unit startpage
  2. Employees
  3. Karina Standahl Olsen
Bilde av Olsen, Karina Standahl
Photo: Kenneth Bowitz Larsen
Bilde av Olsen, Karina Standahl
Associate professor Department of Community Medicine [email protected] +4777644818 90989577 You can find me here

Karina Standahl Olsen

Job description

Karina Standahl Olsen, MSc PhD, is an Associate professor in the Systems Epidemiology research group at the Faculty of Health Sciences, specializing in molecular epidemiology. She leads the UiT Core Facility for Biobanking, UiT's infrastructure for for long term storage, management, and distribution of human biological material collected through population studies and research projects.

With a background in molecular biology and a PhD in molecular epidemiology, her research focuses on blood gene expression, lifestyle, and diet, particularly in the context of cancer. 

She has a diverse background in project and infrastructure management, supervising graduate and undergraduate students, teaching in several topics, as well course leadership of Hel-3060 Epidemiology 2, part of the Master in Public Health program.

 

Link:  UiT Core facility for biobanking

  • Eline Sol Garthsdatter Tylden, Andrè Berli Delgado, Marko Lukic, Line Moi, Lill-Tove Rasmussen Busund, Mona Irene Pedersen et al.:
    Roles of miR-20a-5p in breast cancer based on the clinical and multi-omic (CAMO) cohort and in vitro studies
    Scientific Reports 2024 ARKIV / DOI
  • Sabina Rinaldi, Laure Dossus, Pekka Keski-Rahkonen, Agneta Kiss, Anne-Sophie Navionis, Carine Biessy et al.:
    Circulating endogenous sex steroids and risk of differentiated thyroid carcinoma in men and women
    International Journal of Cancer 2024 DOI
  • David J. Hughes, Lutz Schomburg, Mazda Jenab, Carine Biessy, Catherine Méplan, Aurelie Moskal et al.:
    Prediagnostic selenium status, selenoprotein gene variants and association with breast cancer risk in a European cohort study
    Free Radical Biology & Medicine 2023 ARKIV / DOI
  • Anna Morra, Maartje A. C. Schreurs, Irene L. Andrulis, Hoda Anton-Culver, Annelie Augustinsson, Matthias W. Beckmann et al.:
    Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival
    Cancer Medicine 2023 ARKIV / DOI
  • Carlota Castro-Espin, Catalina Bonet, Marta Crous-Bou, Núria Nadal-Zaragoza, Anne Tjønneland, Lene Mellemkjær et al.:
    Association of Mediterranean diet with survival after breast cancer diagnosis in women from nine European countries: results from the EPIC cohort study
    BMC Medicine 2023 ARKIV / DOI
  • Carlota Castro-Espin, Catalina Bonet, Marta Crous-Bou, Verena Katzke, Charlotte Le Cornet, Franziska Jannasch et al.:
    Dietary patterns related to biological mechanisms and survival after breast cancer diagnosis: results from a cohort study
    British Journal of Cancer 2023 ARKIV / DOI
  • Lucie Lécuyer, Nasser Laouali, Vivian Viallon, Fanny Artaud, James R. Hébert, Nitin Shivappa et al.:
    Associations between dietary inflammatory scores and biomarkers of inflammation in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
    Clinical Nutrition 2023 ARKIV / DOI
  • Gisella Figlioli, Amandine Billaud, Thomas U. Ahearn, Natalia N. Antonenkova, Heiko Becher, Matthias W. Beckmann et al.:
    FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women
    European Journal of Human Genetics 2023 ARKIV / DOI
  • S.G. Yammine, I. Huybrechts, C. Biessy, L. Dossus, S. Panico, M.J. Sánchez et al.:
    Dietary fatty acids and endometrial cancer risk within the European Prospective Investigation into Cancer and Nutrition
    BMC Cancer 2023 ARKIV / DOI
  • Anna Morra, Nasim Mavaddat, Taru A. Muranen, Thomas U. Ahearn, Jamie Allen, Irene L. Andrulis et al.:
    The impact of coding germline variants on contralateral breast cancer risk and survival
    American Journal of Human Genetics 2023 ARKIV / DOI
  • André Berli Delgado, Eline Sol Garthsdatter Tylden, Marko Lukic, Line Haugan Moi, Lill-Tove Rasmussen Busund, Eiliv Lund et al.:
    Cohort profile: The Clinical and Multi-omic (CAMO) cohort, part of the Norwegian Women and Cancer (NOWAC) study
    PLOS ONE 2023 ARKIV / DOI
  • Sanda Krum-Hansen, Karina Standahl Olsen, Endre Anderssen, Jan Ole Frantzen, Eiliv Lund, Ruth H Paulssen :
    Associations of breast cancer related exposures and gene expression profiles in normal breast tissue - The Norwegian Women and Cancer normal breast tissue study
    Cancer Reports 2023 ARKIV / DOI
  • Manon Cairat, Sabina Rinaldi, Anne-Sophie Navionis, Isabelle Romieu, Carine Biessy, Vivian Viallon et al.:
    Circulating inflammatory biomarkers, adipokines and breast cancer risk—a case-control study nested within the EPIC cohort
    BMC Medicine 2022 ARKIV / DOI
  • Marie Breeur, Pietro Ferrari, Laure Dossus, Mazda Jenab, Mattias Johansson, Sabina Rinaldi et al.:
    Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition
    BMC Medicine 2022 ARKIV / DOI
  • Katharina Nimptsch, Krasimira Aleksandrova, Veronika Fedirko, Mazda Jenab, Marc J. Gunter, Peter D. Siersema et al.:
    Pre-diagnostic C-reactive protein concentrations, CRP genetic variation and mortality among individuals with colorectal cancer in Western European populations
    BMC Cancer 2022 ARKIV / DOI
  • Alicia K Heath, Johanna L Clasen, Nick P Jayanth, Mazda Jenab, Anne Tjønneland, Kristina E N Petersen et al.:
    Soft Drink and Juice Consumption and Renal Cell Carcinoma Incidence and Mortality in the European Prospective Investigation into Cancer and Nutrition
    Cancer Epidemiology, Biomarkers and Prevention 2021 ARKIV / DOI
  • Karina Standahl Olsen, Marit Holden, Jean-Christophe Thalabard, Lill-Tove Rasmussen Busund, Eiliv Lund, Lars Holden :
    Global blood gene expression profiles following a breast cancer diagnosis—Clinical follow-up in the NOWAC post-genome cohort
    PLOS ONE 2021 ARKIV / DOI
  • Mathilde His, Vivian Viallon, Laure Dossus, Julie A. Schmidt, Ruth C. Travis, Marc Gunter et al.:
    Lifestyle correlates of eight breast cancer-related metabolites: a cross-sectional study within the EPIC cohort
    BMC Medicine 2021 ARKIV / DOI
  • Michèle Matta, Inge Huybrechts, Carine Biessy, Corinne Casagrande, Sahar Yammine, Agnès Fournier et al.:
    Dietary intake of trans fatty acids and breast cancer risk in 9 European countries
    BMC Medicine 2021 ARKIV / DOI
  • Alicia K. Heath, David C. Muller, Piet A. van den Brandt, Nikos Papadimitriou, Elena Critselis, Marc Gunter et al.:
    Nutrient-wide association study of 92 foods and nutrients and breast cancer risk
    Breast Cancer Research 2020 ARKIV / DOI
  • Einar Holsbø, Karina Standahl Olsen :
    Metastatic Breast Cancer and Pre-Diagnostic Blood Gene Expression Profiles—The Norwegian Women and Cancer (NOWAC) Post-Genome Cohort
    Frontiers in Oncology 2020 ARKIV / DOI
  • Karina Standahl Olsen, Marko Lukic, Kristin Benjaminsen Borch :
    Physical activity and blood gene expression profiles: the Norwegian Women and Cancer (NOWAC) Post-genome cohort
    BMC Research Notes 2020 ARKIV / DOI
  • Marko Lukic, Runa Borgund Barnung, Karina Standahl Olsen, Guri Skeie, Tonje Braaten :
    Coffee consumption and overall and cause-specific mortality: the Norwegian Women and Cancer Study (NOWAC)
    European Journal of Epidemiology (EJE) 2020 ARKIV / DOI
  • Sanda Krum-Hansen, Karina Standahl Olsen :
    Practical and Ethical Issues in Establishing a Collection of Normal Breast Tissue Biopsies—Part of the NOWAC Post-Genome Cohort
    Universitetsforlaget 2020 ARKIV / DOI
  • Fränzel J.B. van Duijnhoven, Mazda Jenab, Kristian Hveem, Peter D. Siersema, Veronika Fedirko, Eric J. Duell et al.:
    Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations
    International Journal of Cancer 2018 DOI
  • Eiliv Lund, Aurelie Nakamura, Igor Snapkov, Jean-Christophe Thalabard, Karina Standahl Olsen, Lars Holden et al.:
    Each pregnancy linearly changes immune gene expression in the blood of healthy women compared with breast cancer patients.
    Clinical Epidemiology 2018 ARKIV / DOI
  • Runa Borgund Barnung, Therese Haugdahl Nøst, Stine Marie Ulven, Guri Skeie, Karina Standahl Olsen :
    Coffee Consumption and Whole-Blood Gene Expression in the Norwegian Women and Cancer Post-Genome Cohort
    Nutrients 09. August 2018 ARKIV / DOI
  • Yury Kiselev, Sigve Andersen, Charles Johannessen, Bjørn Fjukstad, Karina Standahl Olsen, Helge Stenvold et al.:
    Transcription factor PAX6 as a novel prognostic factor and putative tumour suppressor in non-small cell lung cancer
    Scientific Reports 2018 ARKIV / DOI
  • Mie Jareid, Idlir Licaj, Karina Standahl Olsen, Eiliv Lund, Hege Bøvelstad :
    Does an epidemiological comparison support a common cellular lineage for similar subtypes of postmenopausal uterine and ovarian carcinoma? The Norwegian Women and Cancer Study
    International Journal of Cancer 2017 DOI
  • Marit Holden, Lars Holden, Karina Standahl Olsen, Eiliv Lund :
    Local In Time Statistics for detecting weak gene expression signals in blood – illustrated for prediction of metastases in breast cancer in the NOWAC Post-genome Cohort
    Advances in Genomics and Genetics 2017 ARKIV / FULLTEKST / DOI
  • Karina Standahl Olsen, Hege Marie Bøvelstad, Eiliv Lund :
    Systems under your skin
    Oxford University Press 2017 DOI
  • Ana I. Robles, Karina Standahl Olsen, Dana W.T. Tsui, Vassilis Georgoulias, Jenette Creaney, Katalin Dobra et al.:
    Excerpts from the 1st international NTNU symposium on current and future clinical biomarkers of cancer: innovation and implementation, June 16th and 17th 2016, Trondheim, Norway
    Journal of Translational Medicine 19. October 2016 DATA / ARKIV / DOI
  • Susanna Ragnhild Andersdatter Siri, Ann Ragnhild Broderstad, Marita Melhus, Kristin Sørensen, Karina Standahl Olsen, Morten Rafdal et al.:
    Quality assessment of gDNA SST-clots stored for 8 to 18 years - The SAMINOR Study
    2024
  • Karina Standahl Olsen :
    Instagram-bidrag til Brystkreftforskning.no, Rosa sløyfe 2022
    2022 ARKIV
  • Karina Standahl Olsen :
    30 år med brystkreftforskning: Kvinner og Kreft-studien
    2022 FULLTEKST
  • Karina Standahl Olsen, Maike Schönborn, Günther Kalle :
    Functional transcriptomics in 17 year-old blood samples? Yes, we can! -Long-term RNA in situ stability in blood samples collected in PAXgene Blood RNA Tubes (PreAnalytiX GmbH) collected in 2003
    2021 ARKIV
  • Karina Standahl Olsen, Sanda Krum-Hansen, Endre Anderssen, Frantzen Jan-Ole, Eiliv Lund, Ruth H Paulssen :
    Associations of breast cancer related exposures and gene expression profiles in normal breast tissue
    2021
  • Marko Lukic, Runa Borgund Barnung, Guri Skeie, Karina Standahl Olsen, Tonje Braaten :
    Coffee consumption and overall and cause-specific mortality – the Norwegian Women and Cancer Study (NOWAC)
    2019
  • Karina Standahl Olsen, Marko Lukic, Kristin Benjaminsen Borch :
    Physical activity and blood gene expression - The Norwegian Women and Cancer Post-genome cohort
    2019
  • Karina Standahl Olsen, Kurt Jøran Nyland, Kristin Sørensen, Hans-henry Jacobsen :
    The integrated EUTRO system for projects, biobanks, and datasets
    2019
  • Karina Standahl Olsen, Marit Holden, Jean-Christophe Talabard, Lill-Tove Rasmussen Busund, Eiliv Lund, Lars Holden :
    Post-diagnostic blood gene expression profiles in breast cancer - NOWAC Post-genome Cohort
    2019
  • Karina Standahl Olsen :
    Kjernefasilitet for Biobank, UiT
    2018
  • Karina Standahl Olsen, Kjetil Vik :
    Hun er ansvarlig for 1,9 millioner biologiske prøver
    17. March 2017
  • Bjørn Fjukstad, Vanessa Dumeaux, Karina Standahl Olsen, Eiliv Lund, Michael Hallett, Lars Ailo Bongo :
    Building Applications For Interactive Data Exploration In Systems Biology
    2017
  • Karina Standahl Olsen, Eiliv Lund :
    Population-based precision cancer screening-letter
    Cancer Epidemiology, Biomarkers and Prevention 2017 DOI
  • Runa Borgund Barnung, Karina Standahl Olsen, Therese Haugdahl Nøst, Guri Skeie :
    Coffee consumption and whole-blood gene expression in the Norwegian Women and Cancer Post-Genome Cohort
    2017
  • Karina Standahl Olsen, Johanne Røe Mathisen :
    Kroppen vet mer enn legene
    19. July 2016
  • Karina Standahl Olsen :
    Five years before breast cancer diagnosis - blood gene Expression reflects time and clinical parameters
    2016
  • Karina Standahl Olsen, Lars Holden, Hege Bøvelstad, Sandra Plancade, Clara-Cecilie Günther, Jean-Christophe Thalabard et al.:
    Blood gene expression profiles reflect temporality and clinical parameters up to six years before breast cancer diagnosis – The Norwegian Women and Cancer Post-genome cohort (Kvinner og Kreft-studien)
    2016
  • Karina Standahl Olsen, Lars Holden, Hege Bøvelstad, Sandra Plancade, Clara-Cecilie Günther, Jean-Christophe Thalabard et al.:
    Blood gene expression profiles reflect temporality and clinical parameters up to six years before breast cancer diagnosis – The Norwegian
    2016

    • The 50 latest publications is shown on this page. See all publications in Cristin here →

    Research interests

    The research of Karina Standahl Olsen focuses on topics like

    1) Breast cancer and molecular markers: investigating gene expression profiles and other markers in breast tissue and blood, and their association with breast cancer risk factors and outcomes.
    2) Dietary factors and cancer: studying the impact of dietary patterns and nutrient intake on cancer development and progression, with a focus on breast cancer.
    3) Blood biomarkers in cancer: analyzing circulating biomarkers and their relationship with various cancer types, including the role of inflammatory biomarkers in cancer risk.
    4) Practical aspects of research on biobmarkers in cancer: collating sample collections for systems epidemiology and precision medicine, as well as biobanking practices.
    5) Medication use and risk of cancer: modern methodological approaches combined with high-quality cohort and registry data, to address potenial impac of medication use on the risk of cancer (early phase project).

    Publications are listed in the Cristin database.

    Teaching

    Karina Standahl Olsen attained Basic pedagogical competence for teaching in higher education (2016) and have taught at all levels from bachelor’s to PhD, thematically covering cancer, epidemiology, biobanking, nutrition, genomics technology, genetics, and molecular biology. She is the course leader for Hel-3060 Epidemiology 2 (part of the Master’s Degree in Public health, UiT), from 2021-present. 

    Olsen has been a main or co-supervisor for several bachelor and master students, as well as 9 Phd students.

    From 2021 onwards, she has been a member of committees for organizing pedagogical staff development activities in the Teaching unit of epidemiology and biostatistics, ISM, UiT, and has acted as a mentor for colleagues taking the course Basic pedagogical competence for teaching in higher education. Current interests include digital teaching (The European University Alliance for Global Health (EUGLOH) funded project), open teaching resources, and the use of AI tools in teaching.

    Researcher profile in Cristin
    ORCID: https://orcid.org/0000-0002-2539-4603

    Member of research group

    Systemepidemiologi   Norsk innhold Systems Epidemiology   English content

    Member of project

    Korona og immunitet i Norge    Norsk innhold The covid-19 virus and immunity in Norway    English content

    CV

    CURRENT POSITION

    2016-present: Associate professor

    Functions:    
    Head of the Core facility for Biobanking, The Faculty of Health Sciences, UiT
    Research
    Teaching 

     

    EDUCATION

    2016: Basic pedagogical competence for higher education, UiT

    2013: PhD in molecular epidemiology. Thesis title: “Blood gene expression, lifestyle and diet - the Norwegian Women and Cancer Post-genome Cohort”. Department of Community Medicine (ISM), UiT

    2005: Master of Science, Cell- and molecular biology. Dpt. of Laboratory Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway

     

    PREVIOUS POSITIONS

    2016-17: Temporary: associate professor, ISM, UiT (Head of the Core facility for biobanking, researcher)

    2014-16: Post. Doc, Norwegian Women and Cancer study, ISM, UiT *

    2013-14: Researcher, ISM, UiT

    2006-13: PhD student, ISM, UiT **

    2006: Staff engineer, Genomics core facility, NTNU

    *The post.doc. position was shortened due to entering the temporary assoc. prof. position

    **The PhD position was prolonged due to career breaks

     

    COMMISIONS OF TRUST (selection)

    2022-2023: Member of UiT working group for evaluating the national roadmap for research, topic food and health

    2022-present: Member of extended steering group for Dept. of Community Medicine, UiT

    2022-23: Member of Steering group, the Norwegian Women and Cancer study, UiT

    2022-present: Member of Biomarker working group, The Tromsø Study, UiT

    2021- present: Member of Program Board for the Master’s Degree in Public Health, UiT

    2020-present: Member of Steering group for University Hospital of North Norway Research Biobank

    2020-present: Member of Breast Cancer Working Group and Biomarkers Working Group, European Investigation into Nutrition and Cancer (EPIC)

    2016-present: Partner representative for UiT, Biobank Norway Consortium researcher network